ClassID:

97352

C07K2319/73 - CPC Classification

Classification description:

Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)

Recent Application in this class:
#1
20260115254
2026-04-30

IMMUNE-CELL TARGETED BISPECIFIC CHIMERIC PROTEINS AND USES THEREOF

#2
20260034210
2026-02-05

PSEUDO-VIRAL PARTICLES AND USES OF SAME

#3
20250387464
2025-12-25

RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE

#4
20250382342
2025-12-18

A TRUNCATED PROTEIN AND USE THEREOF

#5
20250332199
2025-10-30

MULTI-SWITCH RECEPTOR ARRAYS AND METHODS FOR IMPROVING IMMUNE CELL FUNCTION

#6
20250302875
2025-10-02

TARGETING MODULES AGAINST IL13R-alpha-2 AND/OR HER2 FOR USE IN A METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR-MEDIATED IMMUNE RESPONSE IN A MAMMAL

#7
20250288662
2025-09-18

MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS

#8
20250223601
2025-07-10

FUSION PROTEINS AND METHODS THEREOF

#9
20250223328
2025-07-10

TRUNCATED DOMINANT NEGATIVE CEBPB AND CEBPD PROTEINS AND METHODS OF USE FOR DECREASING VIABILITY OF NEOPLASTIC CELLS

#10
20250188151
2025-06-12

C-JUN ANTAGONIST PEPTIDES

#11
20250163108
2025-05-22

SELF-ASSEMBLING PROTEIN NANOPARTICLES WITH BUILT-IN SIX-HELIX BUNDLE PROTEINS

#12
20250136652
2025-05-01

FUSION PROTEIN FOR TARGETING RECOMBINANT PROTEINS FOR DEGRADATION

#13
20250127849
2025-04-24

ATF5 Peptide Variants and Uses Thereof

#14
20250115886
2025-04-10

DESIGNER MEMBRANELESS ORGANELLES SEQUESTER NATIVE FACTORS FOR CONTROL OF CELL BEHAVIOR

#15
20250101067
2025-03-27

MODIFIED HUMAN CYTOMEGALOVIRUS PROTEINS

#16
20250059578
2025-02-20

SEQUENCES AND METHODS FOR PRODUCTION OF RECOMBINANT BIOLOGICAL MOLECULES IN VESICLES

#17
20250051420
2025-02-13

RECOMBINANT pMHC CLASS II MOLECULES

#18
20250019691
2025-01-16

RNA EXPORT FOR MEASUREMENT AND MANIPULATION OF CELLS

#19
20250011433
2025-01-09

FUSION PROTEINS OF HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN FC COMPOSITIONS WITH ENHANCED COMPLEMENT BINDING

#20
20240383967
2024-11-21

HUMANIZED ANTIBODY INHIBITORS FOR CATHEPSIN S

#21
20240383951
2024-11-21

FUSION PROTEINS OF NATURAL HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN Fc COMPOSITIONS

#22
20240360181
2024-10-31

COMPOSITIONS AND METHODS FOR MULTIVALENT SURFACE DISPLAY ON ENVELOPED PARTICLES

#23
20240343790
2024-10-17

SCFV-FC DIMERS THAT BIND TRANSFORMING GROWTH FACTOR-BETA1 WITH HIGH AFFINITY, AVIDITY AND SPECIFICITY

#24
20240317807
2024-09-26

MCL-1 BINDING ALPHABODIES AND USES THEREOF

#25
20240287530
2024-08-29

FUSION PROTEINS AND METHODS THEREOF

#26
20240270815
2024-08-15

Antigen Presenting Polypeptide Complexes and Methods of Use Thereof

#27
20240269329
2024-08-15

GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY

#28
20240254203
2024-08-01

ANTIBODY-BASED ANTIVIRUS COMPOSITIONS AND METHODS OF USE

#29
20240247275
2024-07-25

FUSION PROTEINS AND METHODS THEREOF

#30
20240181003
2024-06-06

ATF5 peptide variants and uses thereof

#31
20240132857
2024-04-25

FUSION PROTEINS COMPRISING TWO RING DOMAINS

#32
20240075152
2024-03-07

SUPRAMOLECULAR ASSEMBLIES, COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME

#33
20240033343
2024-02-01

MODIFIED POLYPEPTIDES WITH IMPROVED PROPERTIES

#34
20240024458
2024-01-25

Recombinant metapneumovirus f proteins and their use

#35
20230365695
2023-11-16

COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF

#36
20230348574
2023-11-02

RSV F protein compositions and methods for making same

#37
20230321183
2023-10-12

CAL-T CONSTRUCTS AND USES THEREOF

#38
20230265127
2023-08-24

STABILIZED SOLUBLE PRE-FUSION RSV F POLYPEPTIDES

#39
20230203123
2023-06-29

METHODS AND COMPOSITIONS RELATING TO CHIMERIC ANTIGEN RECEPTORS

#40
20230192810
2023-06-22

ARTIFICIAL EXCITATORY SYNAPSE CONNECTOR AND USE THEREOF FOR SPINAL CORD INJURY

#41
20230064668
2023-03-02

Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof

#42
20230054711
2023-02-23

MULTIMERIZATION DELIVERY SYSTEM FOR INTRACELLULAR DELIVERY OF MOLECULE

#43
20230025108
2023-01-26

Rapid assay for detection of SARS-CoV-2 antibodies

#44
20220372115
2022-11-24

RSV F protein compositions and methods for making same

#45
20220363740
2022-11-17

scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidity and specificity

#46
20220340645
2022-10-27

RSV F protein compositions and methods for making same

#47
20220306727
2022-09-29

Methods of Purifying Masked Antibodies

#48
20220275043
2022-09-01

SOLUBLE MULTIMERIC IMMUNOGLOBULIN-SCAFFOLD BASED FUSION PROTEINS AND USES THEREOF

#49
20220265837
2022-08-25

COMPLEX FOR INTRACELLULAR DELIVERY OF MOLECULES

#50
20220242930
2022-08-04

IMMUNOMODULATORY PROTEINS WITH TUNABLE AFFINITIES

#51
20220235145
2022-07-28

Proximity-based sortase-mediated protein purification and ligation

#52
20220226441
2022-07-21

IMMUNE-CELL TARGETED BISPECIFIC CHIMERIC PROTEINS AND USES THEREOF

#53
20220214352
2022-07-07

Rapid assay for detection of SARS-CoV-2 antibodies

#54
20220213177
2022-07-07

RSV F protein compositions and methods for making same

#55
20220135674
2022-05-05

CD47 antibodies and uses thereof for treating cancer

#56
20220098258
2022-03-31

GALECTIN-1/ GALECTIN-3 CHIMERAS AND MULTIVALENT PROTEINS

#57
20220056087
2022-02-24

Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions

#58
20220033450
2022-02-03

VIRALLY EXPRESSED INHIBITORS OF PDZ DOMAINS, SUCH AS PICK1 AND USES THEREOF

#59
20210380653
2021-12-09

Trail compositions with reduced immunogenicity

#60
20210283240
2021-09-16

Recombinant metapneumovirus F proteins and their use

#61
20210277059
2021-09-09

Stabilized minimal coiled-coil mimetics

#62
20210179686
2021-06-17

CELL SORTING SYSTEMS AND METHODS OF USE

#63
20210171601
2021-06-10

LEUCINE ZIPPER-BASED COMPOSITIONS AND METHODS OF USE

#64
20210113653
2021-04-22

CAL-T constructs and uses thereof

#65
20210101940
2021-04-08

Stabilized Soluble Pre-Fusion RSV F Polypeptides

#66
20210094989
2021-04-01

Silk Proteins

#67
20210087279
2021-03-25

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

#68
20210061869
2021-03-04

ATF5 peptide variants and uses thereof

#69
20210040161
2021-02-11

Modular dimerization thermoswitches and related monomers, dimers, constructs, dimeric complexes, vectors, cells, surfaces, devices compositions, methods and systems

#70
20200407416
2020-12-31

Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof

#71
20200400567
2020-12-24

FUSION POLYPEPTIDE

#72
20200399341
2020-12-24

Compbody—a multivalent target binder

#73
20200317805
2020-10-08

Split superantigens and their use for immunotherapy

#74
20200300860
2020-09-24

Fusion proteins and methods thereof

#75
20200277403
2020-09-03

Proximity-based sortase-mediated protein purification and ligation

#76
20200270353
2020-08-27

Coiled coil immunoglobulin fusion proteins and compositions thereof

#77
20200174003
2020-06-04

Fusion proteins and methods thereof

#78
20200172600
2020-06-04

RSV F protein compositions and method for making same

#79
20200131258
2020-04-30

scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidity and specificity

#80
20200095333
2020-03-26

Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life

#81
20200087355
2020-03-19

Catalytically active protein aggregates and methods for producing the same

#82
20200062814
2020-02-27

Modified Latency Associated Protein Construct

#83
20200062813
2020-02-27

Improved Loading of EVs with Therapeutic Proteins

#84
20200038493
2020-02-06

Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy

#85
20200033353
2020-01-30

Fusion proteins and methods thereof

#86
20200017554
2020-01-16

SELF-ASSEMBLING PROTEIN NANOPARTICLES WITH BUILT-IN SIX-HELIX BUNDLE PROTEINS

#87
20200009243
2020-01-09

Recombinant metapneumovirus F proteins and their use

#88
20190352428
2019-11-21

Bivalent antibodies masked by coiled coils

#89
20190351021
2019-11-21

Immune-cell targeted bispecific chimeric proteins and uses thereof

#90
20190270813
2019-09-05

Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof

#91
20190218264
2019-07-18

Targeted effector proteins and uses thereof

#92
20190185561
2019-06-20

CD47 antibodies and uses thereof for treating cancer

#93
20190135878
2019-05-09

Regulating electron flow using fragmented proteins

#94
20180371104
2018-12-27

Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life

#95
20180346541
2018-12-06

Methods and compositions relating to chimeric antigen receptors

#96
20180256698
2018-09-13

PROLINE-RICH PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE

#97
20180244772
2018-08-30

Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin Fc compositions with enhanced complement binding

#98
20180244749
2018-08-30

Immunomodulatory proteins with tunable affinities

#99
20180236065
2018-08-23

Coiled-coil connector

#100
20180222970
2018-08-09

ScFv-Fc dimers that bind transforming growth factor-BETA1 with high affinity, avidity and specificity

#101
20180162907
2018-06-14

Stabilized minimal coiled-coil mimetics

#102
20180030100
2018-02-01

Non-natural Semaphorins 3 and their medical use

#103
20180016335
2018-01-18

Chimeric antigen receptor signalling system comprising heterodimerization domains

#104
20180008697
2018-01-11

Recombinant metapneumovirus F proteins and their use

#105
20180002388
2018-01-04

Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions

#106
20170342113
2017-11-30

RECOMBINANT H7 HEMAGGLUTININ AND USE THEREOF

#107
20170313747
2017-11-02

SELF-ASSEMBLED NANOSTRUCTURES

#108
20170210818
2017-07-27

CONSTANT REGION ANTIBODY FUSION PROTEINS AND COMPOSITIONS THEREOF

#109
20170210813
2017-07-27

Anti-PDGFR-beta antibodies and uses thereof

#110
20170129931
2017-05-11

Modified latency associated protein construct

#111
20170073386
2017-03-16

GITRL fusion proteins comprising a human coronin 1a derived trimerization domain

#112
20170058050
2017-03-02

Covalently linked helicar-anti-helicar antibody conjugates and uses thereof

#113
20170058010
2017-03-02

Methods and pharmaceutical compositions for the treatment of cancer

#114
20170051025
2017-02-23

Silk Proteins

#115
20170049883
2017-02-23

Synthetic hapten carrier compositions and methods

#116
20170044269
2017-02-16

ADENOVIRAL TARGETING, COMPOSITIONS AND METHODS THEREFOR

#117
20170044217
2017-02-16

Prophylactic vaccine against egg drop syndrome (EDS)

#118
20160362455
2016-12-15

Influenza virus vaccines and uses thereof

#119
20160324947
2016-11-10

Proline-rich peptides protective against

#120
20160305948
2016-10-20

Charged peptide appendage to facilitate oriented protein covalent immobilization

#121
20160304584
2016-10-20

MAFB MUTANTS AND USES THEREOF

#122
20160289339
2016-10-06

Anti-human mIgA antibodies capable of lysing mIgA-B lymphocytes and decreasing IgA production

#123
20160280761
2016-09-29

Human leucine zipper/trail recombinant polypeptides

#124
20160279253
2016-09-29

Methods of administering an N-terminal modified PEG-TRAIL

#125
20160220727
2016-08-04

Self-assembling underwater adhesives

#126
20160206713
2016-07-21

Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy

#127
20160194396
2016-07-07

Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof

#128
20160188790
2016-06-30

Rotavirus particles with chimeric surface proteins

#129
20160176932
2016-06-23

Stabilized soluble pre-fusion RSV F polypeptides

#130
20160168558
2016-06-16

Compositions, methods and kits for real-time nucleic acid analysis in live cells

#131
20160159920
2016-06-09

Coiled coil immunoglobulin fusion proteins and compositions thereof

#132
20160122433
2016-05-05

Anti-PDGFR-beta antibodies and uses thereof

#133
20160102123
2016-04-14

Stabilized soluble pre-fusion RSV F polypeptides

#134
20160024485
2016-01-28

Use of dimerization domains for temperature regulation of enzyme activity

#135
20160022776
2016-01-28

Trail receptor agonists for treatment of fibrotic disease

#136
20160002356
2016-01-07

Coiled coil and/or tether containing protein complexes and uses thereof

#137
20160002305
2016-01-07

Artificial bioparticle and method of manufacturing the same

#138
20150361142
2015-12-17

Vaccine for preventing porcine edema disease

#139
20150266968
2015-09-24

Polypeptides capable of cellular internalization

#140
20150259397
2015-09-17

Long acting TRAIL receptor agonists for treatment of autoimmune diseases

#141
20150175697
2015-06-25

Deimmunized serum-binding domains and their use in extending serum half-life

#142
20150094450
2015-04-02

Repebody for novel interleukin-6 and use thereof

#143
20150094271
2015-04-02

Leucine zipper variant and use thereof

#144
20150093406
2015-04-02

Modified coiled coil type proteins having improved properties

#145
20150031127
2015-01-29

Self-assembled nanostructures

#146
20140377243
2014-12-25

Cell-penetrating fusion protein for regenerating or proliferating stem cell

#147
20140357845
2014-12-04

Influenza virus vaccines and uses thereof

#148
20140206843
2014-07-24

Therapeutic TRAIL fusion protein and preparation and use thereof

#149
20140112936
2014-04-24

Antigenic polypeptides comprising pre-hairpin intermediate conformations of HIV-1 GP41

#150
20140093532
2014-04-03

Immunogenic compositions in particulate form and methods for producing the same

#151
20130251712
2013-09-26

Covalently dimerized bivalent binding agents

#152
20130231274
2013-09-05

Fusion protein having transcription factor transactivation-regulating domain and protein transduction domain, and transcription factor function inhibitor comprising the same

#153
20130115218
2013-05-09

Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides

#154
20130034578
2013-02-07

RECOMBINANT MULTIMERIC INFLUENZA PROTEINS

#155
20130029358
2013-01-31

IMMUNODOMINANT MHC DR52B RESTRICTED NY-ESO-1 EPITOPES, MHC CLASS II MONOMERS AND MULTIMERS, AND USES THEREOF

#156
20130005666
2013-01-03

Reporter system for high throughput screening of compounds and uses thereof

#157
20120302737
2012-11-29

COILED COIL AND/OR TETHER CONTAINING PROTEIN COMPLEXES AND USES THEREOF

#158
20120301899
2012-11-29

Podocalyxin-like-protein-1 binding antibody molecule

#159
20120294883
2012-11-22

OLIGOMERIC RECEPTOR LIGAND PAIR MEMBER COMPLEXES

#160
20120251503
2012-10-04

Method for inducing angiogenesis in an infarcted heart by administering a coiled coil chimeric molecule

#161
20120245103
2012-09-27

Silk proteins

#162
20120190610
2012-07-26

Tetranectin-apolipoprotein A-I, lipid particles containing it and its use

#163
20120178912
2012-07-12

Receptor activator of NF-kappaB

#164
20120165204
2012-06-28

Genetically encoded photomanipulation of protein and peptide activity

#165
20120164176
2012-06-28

RSV F PROTEIN COMPOSITIONS AMD METHODS FOR MAKING SAME

#166
20120148527
2012-06-14

TNF superfamily member light fusion proteins

#167
20120135028
2012-05-31

Vaccine

#168
20120100165
2012-04-26

Drug transporter, and adjuvant and vaccine each utilizing same

#169
20120093847
2012-04-19

Recombinant RSV vaccines

#170
20120040900
2012-02-16

Compositions of and methods of using ligand dimers

#171
20120034690
2012-02-09

Cells and methods for producing blocking antibodies to human RANKL

#172
20120015819
2012-01-19

Mixture of at least two fusion proteins, the production thereof and the use of the same

#173
20120009211
2012-01-12

BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS

#174
20110305727
2011-12-15

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

#175
20110200990
2011-08-18

Kits for detecting rank

#176
20110189234
2011-08-04

ADENOVIRUS PARTICLES HAVING A CHIMERIC ADENOVIRUS SPIKE PROTEIN, USE THEREOF AND METHODS FOR PRODUCING SUCH PARTICLES

#177
20110104753
2011-05-05

Soluble recombinant influenza antigens

#178
20110086033
2011-04-14

Method of inhibiting osteoclast activity

#179
20110028403
2011-02-03

HSP70-Based Treatment for Autoimmune Diseases and Cancer

#180
20110027267
2011-02-03

Fusion Proteins of Mannose Binding Lectins for Treatment of Disease

#181
20110027218
2011-02-03

CD95L or trail fusion proteins

#182
20110020267
2011-01-27

Tweak receptor

#183
20100305002
2010-12-02

Reagents and Methods for Producing Bioactive Secreted Peptides

#184
20100291147
2010-11-18

Recombinant RSV antigens

#185
20100256042
2010-10-07

Method of treating a cutaneous wound using a coiled coil chimeric molecule

#186
20100221241
2010-09-02

CONSTRAINED HIV ENVELOPE-BASED IMMUNOGEN THAT SIMULTANEOUSLY PRESENTS RECEPTOR AND CORECEPTOR BINDING SITES

#187
20100183548
2010-07-22

Tweak receptor

#188
20100105876
2010-04-29

Method for the oligomerisation of peptides

#189
20100100975
2010-04-22

Silk proteins

#190
20100055794
2010-03-04

Selection of cells expressing heteromeric polypeptides

#191
20100041025
2010-02-18

Methods of detecting transcription

#192
20100022756
2010-01-28

Trimerising module

#193
20100003719
2010-01-07

Trimerising module

#194
20090311690
2009-12-17

VECTOR FOR SCREENING ANTIBODY

#195
20090291504
2009-11-26

CRE COMPLEMENTATION USING LEUCINE ZIPPER

#196
20090215197
2009-08-27

Target substance capturing molecule

#197
20090203599
2009-08-13

N-terminal modified PEG-TRAIL

#198
20090170220
2009-07-02

Bispecific capturing molecule

#199
20090137472
2009-05-28

CHIMERIC MHC PROTEIN AND OLIGOMER THEREOF

#200
20090137036
2009-05-28

TWEAK receptor

#201
20090137035
2009-05-28

Tweak receptor

#202
20090136467
2009-05-28

APOLIPOPROTEIN ANALOGUES

#203
20090053252
2009-02-26

BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUATROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS

#204
20090028884
2009-01-29

OLIGOMERIC RECEPTOR LIGAND PAIR MEMBER COMPLEXES

#205
20090017033
2009-01-15

Methods for interfering with rank signaling

#206
20090011000
2009-01-08

Inhibitors of Infection

#207
20090004196
2009-01-01

Method of inhibiting osteoclast activity

#208
20080287304
2008-11-20

Mixture of at Least Two Fusion Proteins as Well as Their Production and Use

#209
20080280346
2008-11-13

System For the Production of Dimeric Proteins Based on the Transport System of Hemolysin of Escherichia Coli

#210
20080213295
2008-09-04

HER-2/neu fusion proteins

#211
20080199479
2008-08-21

Method of treating a muscle-related condition with modified IGF1 polypeptides

#212
20080009014
2008-01-10

Kits for detecting rank nucleic acids

#213
20070298996
2007-12-27

Methods of using chimeric coiled coil molecule to treat ischemic disease

#214
20070196816
2007-08-23

Engineered stimulus-responsive switches

#215
20070160628
2007-07-12

Stabilized virus-like particles and epitope display systems

#216
20070154994
2007-07-05

Coiled-coil fusion proteins comprising cell receptor domains

#217
20070154901
2007-07-05

Trimerising module

#218
20070123457
2007-05-31

Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof

#219
20070031422
2007-02-08

Selection of cells expressing heteromeric polypeptides

#220
20070010658
2007-01-11

Trimeric binding proteins for trimeric cytokines

#221
20060235201
2006-10-19

Enduring T cell response

#222
20060233808
2006-10-19

Peptabody for cancer treatment

#223
20060148017
2006-07-06

Compositions and methods for monitoring enzyme activity

#224
20060094030
2006-05-04

Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics

#225
20060084143
2006-04-20

TWEAK receptor

#226
20060046291
2006-03-02

Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics

#227
20050287151
2005-12-29

Modified IGF1 polypeptides with increased stability and potency

#228
20050260194
2005-11-24

Immunoglobulin chimeric monomer-dimer hybrids

#229
20050220817
2005-10-06

Stabilized soluble glycoprotein trimers

#230
20050208046
2005-09-22

TWEAK receptor

#231
20050142639
2005-06-30

Method of producing apolipoprotein analogues

#232
20050106177
2005-05-19

Stabilized soluble glycoprotein trimers

#233
20050096459
2005-05-05

Oligomeric receptor ligand pair member complexes

#234
20050096277
2005-05-05

Methods of prevention and treatment using apolipoprotein analogues

#235
20050089522
2005-04-28

Methods of inhibiting osteoclastogenesis

#236
20050084885
2005-04-21

Zinc finger protein derivatives and methods therefor

#237
20050054047
2005-03-10

Compositions and methods relating to multimeric and oligomeric soluble fragments of the TWEAK receptor

#238
20050048471
2005-03-03

Albumin derivatives with therapeutic functions

#239
20050031628
2005-02-10

Chimeric antigens for breaking host tolerance to foreign antigens

#240
20050015232
2005-01-20

Computer-based methods of designing molecules

#241
20050003391
2005-01-06

Monoclonal blocking antibody to human RANKL

#242
17140321
2021-11-16

Rapid assay for detection of SARS-CoV-2 antibodies